On April 21, 2026, Dr. Jay Bhattacharya, the current head of the Centers for Disease Control and Prevention and director of the National Institutes of Health, sent a formal rejection letter to the authors of a peer-reviewed COVID-19 vaccine-effectiveness study that had cleared the CDC's internal scientific review and was scheduled for publication in the Morbidity and Mortality Weekly Report (CNN, April 22, 2026). The blocked study reported that COVID-19 vaccines "roughly halved" the chances that a US adult would need an emergency room visit or hospitalization for COVID infection during the 2025 to 2026 fall and winter, drawing on the CDC-led VISION collaboration's electronic-health-record data from nine US health systems.
The political fight over what Bhattacharya did on April 21 is being covered upstream by mainstream health press. The downstream story is what the block means for the citation chain that Black-health journalism depends on.
What MMWR is and why our reporting depends on it
MMWR is the CDC's peer-reviewed weekly outlet for surveillance findings, most of which are stratified by race and ethnicity. NCHS Health E-Stat 100 (Hoyert 2024 maternal mortality), Health E-Stat 113 (Hoyert 2024 update), CDC WONDER mortality queries, and the agency's pediatric and chronic-disease surveillance briefs all flow through editorial review processes downstream of MMWR's standards. Our piece on the Black-white maternal mortality gap widening to 3.5 times in 2023 cites Hoyert's NCHS Health E-Stat directly. Our piece on why finding a Black doctor is harder than it should be draws on CDC and AAMC workforce numbers from the same surveillance ecosystem.
The agency's ability to publish race-stratified findings on a regular cadence is what makes Black-disparity reporting possible at the depth this site tries to maintain. When Bhattacharya rejects a study that cleared internal review, the question is what the editorial pipeline looks like for the next race-stratified surveillance brief, and the one after that.
The blocked study used the standard test-negative design
The VISION collaboration's full name is the Virtual SARS-CoV-2, Influenza and Other Respiratory Viruses Network. It pulls electronic health records from nine US health systems to monitor vaccine effectiveness across seasons and demographic groups. The methodology Bhattacharya rejected, the test-negative design, looks at all the people who go to the doctor for a specific symptom set, then compares vaccination status of those who test positive for a given infection against those who test negative (CNN, April 22, 2026). The design helps minimize the healthy-user bias that would otherwise distort vaccine effectiveness estimates.
The test-negative design is the standard methodology for measuring vaccine effectiveness against COVID-19, influenza, and respiratory syncytial virus. Studies using it have been published in the New England Journal of Medicine and The Lancet across multiple respiratory-virus seasons.
What named scientists who left the CDC say
Dr. Fiona Havers, MD, MHS, who resigned as senior vaccine policy adviser at the CDC in June 2025 over changes to vaccine policy made by HHS Secretary Robert F. Kennedy Jr. and was previously part of the team working with VISION data, told CNN the rejection was "pretty problematic in general, because it's a very standard, well-established study design that has been used for a long time" (CNN, April 22, 2026). She added that the rejection looks like "pretty aggressive interference by a political appointee into CDC scientific processes."
Dr. Deb Houry, MD, MPH, who served as the CDC's chief medical officer until she resigned in August 2025 in solidarity with Dr. Susan Monarez (the short-tenured CDC director Kennedy ousted weeks into her role), told CNN that Bhattacharya's request for a methodology change was "really too late after the fact" and that during her four years reviewing MMWR submissions in her acting principal deputy and chief medical officer roles, she "very rarely rejected a paper late this in the process" (CNN, April 22, 2026). The rejection was first reported by the Washington Post.
Three concrete cite-chain risks for Black-health reporting
The risks for our reporting and our readers fall into three buckets.
First, future MMWR briefs may reflect editorial intervention rather than pure scientific review. A Black-disparity finding that does not land politically the same way as the COVID-19 vaccine-effectiveness paper is the next test. We will treat any post-April-21 MMWR brief as carrying that possible editorial fingerprint until further evidence one way or the other.
Second, historical MMWR data we cite on this site is from before the editorial-intervention window and remains fully usable. The Hoyert NCHS Health E-Stat 100 maternal mortality figures we cite, the CDC WONDER queries our Black-white maternal mortality gap piece draws on, the workforce data behind our find-a-Black-doctor piece all predate this window. Yesterday's data is not in question; today's editorial pipeline is.
Third, downstream NCHS Health E-Stat publications use the same editorial chain that runs through MMWR. The maternal mortality briefs, the pediatric mortality briefs, the chronic disease briefs, the firearm injury surveillance, the opioid death surveillance: all of them flow through review processes that can be subjected to the same editorial intervention Bhattacharya used here. The framing is "the data we cited yesterday is fine; the data we cite tomorrow may carry an editorial fingerprint."
What a Black-health reader can do this week
Three concrete moves, none of them require federal-policy expertise.
First, when citing CDC numbers in conversations with providers (or in advocacy work, or in public comment), name the publication date. A maternal mortality figure published in 2024 from 2022 data is from before the editorial-intervention window; a brief published in late 2026 from late-2025 data is the kind of thing that may carry the post-April-21 editorial fingerprint, and naming the date in your conversation lets the listener weigh the source accordingly.
Second, cross-check MMWR figures against the underlying NVSS, CDC WONDER, or HRSA raw data when possible. The raw data feeds are not as easily intervened-upon as the published interpretive briefs are. CDC WONDER is queryable directly at wonder.cdc.gov for mortality, natality, and population data; NVSS public-use files are downloadable. The published brief is one interpretation; the underlying counts are reproducible.
Third, watch for resignations and editorial-board changes at NCHS as forward indicators of further editorial-policy shifts. The Houry, Monarez, and Havers departures are documented; another similar departure or a change at the NCHS director level would be the next signal. Any deeper change to the federal surveillance pipeline starts with personnel before it shows up in the published briefs.
Update plan
We will update this piece if Bhattacharya is replaced, if the blocked study is published in another peer-reviewed venue, if additional MMWR or NCHS publications are blocked, or if an NCHS editorial-board reshuffle is announced.
Citations
Tirrell M, Christensen J. Trump appointees blocked publication of a CDC study showing Covid-19 vaccines work. CNN, April 22, 2026. cnn.com.
US Centers for Disease Control and Prevention. Morbidity and Mortality Weekly Report. cdc.gov/mmwr.
US Centers for Disease Control and Prevention. CDC WONDER. wonder.cdc.gov.
Malik Johnson is a senior staff writer covering Black health. Send tips to malik@blackhealth.org.
